CMV-specific T-Cells for treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: first application in Turkey

Celilova, SevilToret, ErsinAksoy, BaşakOvalı, ErcümentBozkurt, Ceyhun2021-05-152021-05-152020Celilova, S., Toret, E., Adakli Aksoy, B., Ovali, E., Bozkurt, C. (2020). CMV-specific T-Cells for Treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: First application in Turkey. Turkish Journal of Hematology, 37(1), 57-76.1300-77771308-5263https://doi.org/10.4274/tjh.galenos.2019.2019.0293https://app.trdizin.gov.tr/makale/TXpZMU1UZzJOZz09https://hdl.handle.net/20.500.12939/1264Cytomegalovirus (CMV) infection is still a major complication after allogeneic hematopoietic stem cell transplantation (HSCT) [1,2]. Unfortunately, prolonged antiviral treatment of CMV infection causes a delayed CMV-specific immune reconstitution. At this point, adoptive immunotherapy by CMV-specific T-cells can control CMV infection or provide immune reconstruction.eninfo:eu-repo/semantics/closedAccessChildhoodHematopoietic Stem Cell TransplantCMVSpecific T-CellTherapyInternal MedicineRC31-1245Diseases Of The Blood And Blood-Forming OrgansRC633-647.5CMV-specific T-Cells for treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: first application in TurkeyPediatrik bir olguda HKHN sonrası CMV spesifik t hücre kullanımı: Türkiye’deki ilk uygulamaLetter10.4274/tjh.galenos.2019.2019.029337165672-s2.0-85080844385Q3365186WOS:000514819900015Q3